Search

iRhythm Technologies Inc

Gesloten

SectorGezondheidszorg

125.36 2.39

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

122.43

Max

125.83

Belangrijke statistieken

By Trading Economics

Inkomsten

14M

-381K

Verkoop

25M

224M

EPS

0.58

Winstmarge

-0.17

Werknemers

2,400

EBITDA

6.5M

2.9M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+39.43% upside

Dividenden

By Acuity

Volgende Winsten

29 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

16M

4.1B

Vorige openingsprijs

122.97

Vorige sluitingsprijs

125.36

Nieuwssentiment

By Acuity

15%

85%

30 / 340 Rangschikking in Healthcare

iRhythm Technologies Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 aug 2026, 20:06 UTC

News

iRhythm Technologies reported second-quarter revenue of $224.2 million, exceeding estimates, but shares are trading lower during Thursday's session.

12 aug 2026, 19:56 UTC

iRhythm Technologies Inc. shares are higher Wednesday, reflecting positive market conditions despite earlier session pullbacks and recent downward pressure.

11 aug 2026, 20:06 UTC

iRhythm Technologies shares are lower today, continuing a downward trend since Monday's close, despite stabilizing above the 20-day moving average.

10 aug 2026, 19:41 UTC

News

iRhythm Technologies shares lower today despite Truist raising the price target to $168.00 and reporting Q2 sales of $224.2 million.

7 aug 2026, 19:51 UTC

News

iRhythm Technologies is higher today, driven by strong earnings of $224.17 million and its acquisition of VitalConnect for $287.5 million.

6 aug 2026, 23:02 UTC

News

iRhythm Technologies shares rise in after-market trading following strong Q2 results, $224.2 million in revenue, and an acquisition of VitalConnect for $287.5 million.

5 aug 2026, 19:46 UTC

News

iRhythm Technologies shares are lower amid cautious market sentiment following ADP's report of disappointing private sector job growth. Earnings are due August 6.

4 aug 2026, 21:01 UTC

iRhythm Technologies Inc shares rose in after-market hours, reflecting a broader market rally amid positive sentiment from U.S.-Iran negotiations and falling crude oil prices.

3 aug 2026, 20:03 UTC

iRhythm Technologies Inc shares are rising, driven by gains in the Health Care Equipment sub-sector and overall strong market performance.

31 jul 2026, 21:01 UTC

iRhythm Technologies Inc shares advanced in after-hours trading, reflecting unusual strength amid rising inflation concerns and geopolitical tensions affecting oil prices.

30 jul 2026, 19:43 UTC

iRhythm Technologies Inc is lower today, influenced by declines in the Health Care Equipment sub-sector. This follows five consecutive sessions of gains.

29 jul 2026, 19:52 UTC

Macro Event

iRhythm Technologies shares are higher today, reflecting positive momentum after the Federal Reserve maintained interest rates amid easing inflation concerns.

28 jul 2026, 18:03 UTC

iRhythm Technologies is higher today, driven by gains in the Health Care Equipment sub-sector. Shares pulled back from earlier session highs.

27 jul 2026, 20:06 UTC

iRhythm Technologies Inc shares are higher amid positive market sentiment, driven by a decline in oil prices and easing geopolitical tensions.

24 jul 2026, 20:06 UTC

iRhythm Technologies Inc shares are trading higher, reflecting positive sentiment amid falling oil prices that ease inflation concerns. No specific company news was identified.

23 jul 2026, 09:01 UTC

iRhythm Technologies Inc is trading higher in pre-market hours, reflecting a notable gain since Wednesday's close. No specific news was identified for this movement.

21 jul 2026, 18:56 UTC

News

iRhythm Technologies is under investigation for potential wrongdoing by certain officers and directors, contributing to lower trading during Tuesday's session.

20 jul 2026, 19:16 UTC

iRhythm Technologies Inc is trading higher Monday, having reached a peak cumulative return earlier in the session. No specific news was identified to explain the movement.

Peer Vergelijking

Prijswijziging

iRhythm Technologies Inc Prognose

Koersdoel

By TipRanks

39.43% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 174.78 USD  39.43%

Hoogste 196 USD

Laagste 157 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor iRhythm Technologies Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

11

Buy

0

Hold

0

Sell

Sentiment

By Acuity

30 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat